Starting Material Stabilization
Wound therapy cells are sourced from a skin biopsy or a marrow or adipose harvest, and the interval between collection and processing exposes the tissue and its cells to temperature shifts, handling, and surface contact. Cell viability at this stage affects the yield recovered for culture. A stabilizing protein in the transport or hold solution supports cell health before isolation begins.
Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.
- Commonly replaces
- Serum or plasma-derived albumin in tissue transport and hold solutions.